Researcher biography

Dr Kevin M. Koo is currently a National Health and Medical Research Council (NHMRC) Investigator Fellow and Prostate Cancer Foundation of Australia (PCFA) Future Leader Fellow at The University of Queensland (UQ). Dr Koo was awarded his PhD (Dean's Award for Outstanding Thesis & Springer Thesis Prize) from the Australian Institute for Bioengineering & Nanotechnology (AIBN), UQ in 2018.

Post-PhD, he begun a productive postdoctoral career with dual industry/academia appointments: as the Head of Assay Development/Lab Director in XING Technologies Pty Ltd (a Brisbane-based biotech start-up) to undertake product development projects for commercialization of disease in vitro diagnostics, and as an Honorary Fellow/Principal Research Scientist at UQ Centre for Clinical Research (UQCCR) to continue his academic research in precision cancer nanodiagnostics. His research skills and experiences are honed through dedicated career time spent in both academic research and regulated industry environments.

Dr Koo's research encompasses multi-disciplinary fields of molecular biomarker and nanobiosensor development, translation, and commercialization for precision disease management applications. Presently, he is working on the design and development of integrated multi-bioanalyte sensing technologies to resolve the various challenges around holistic disease pathway understanding and clinical biomarker profiling.

Dr Koo's research endeavours have been recognized by a Metrohm Australia-New Zealand Young Chemist Award (2018), Australian Institute of Policy & Science (AIPS) Queensland Young Tall Poppy Science Award (2023) and UQ Faculty of Medicine "Rising Star of the Year" Excellence Award (2024).

Teaching

UQ School of School of Chemistry and Molecular Biosciences (SCMB)

BIOT7018 Biologics: Course Coordinator 2025-2026

BIOC7001 Advanced Molecular Biology Laboratory: Guest Lecturer 2024-2025

BIOC6001 Introduction to Molecular Biology Laboratory: Guest Lecturer 2024